Accumulative No. of Treated (DAA and/or Interferon)3
183,074
1. ML Yu, et al. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan. Medicine 2015 (94): 13: e690
2. Taiwan government provides free screening for age group of 45-79 year-old.
3. The cumulative number of screenings and treatments, including all individuals aged 45-79.